Class IITerminatedD-0919-2017
Drug recall · June 21, 2017
ESTRONE USP recall
Why: cGMP Deviations; lack of quality assurance.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
ESTRONE USP, packaged in a) 1g bottle (NDC: 58597-8049-2), c) 5g bottle (NDC: 58597-8049-3), d) 25g bottle (NDC: 58597-8049-4), For Prescription Compounding, RX Only, Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC, 6650 Highland Road, Waterford, MI 48327
- Lots / codes
Lots: 052915-1, 052915-2, exp 5/5/2017
- Quantity
- 1g=1 bottle; 5g=4 bottle; 25g=3 bottles
- Company
- American Pharmaceutical Ingredients LLC, Waterford, MI
- Distribution
- NY, GA, NV, CA, KY, TX
- Initiated
- April 17, 2017 · Voluntary: Firm initiated
- Classified
- June 15, 2017
- Reported
- June 21, 2017
- Ended
- May 31, 2018
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.